CLGN
Price
$3.14
Change
+$0.31 (+10.95%)
Updated
Sep 26 closing price
Capitalization
39.93M
59 days until earnings call
NEVPF
Price
$0.03
Change
-$0.00 (-0.00%)
Updated
Jan 23 closing price
Capitalization
45.13M
Interact to see
Advertisement

CLGN vs NEVPF

Header iconCLGN vs NEVPF Comparison
Open Charts CLGN vs NEVPFBanner chart's image
CollPlant Biotechnologies
Price$3.14
Change+$0.31 (+10.95%)
Volume$41.77K
Capitalization39.93M
Abliva AB
Price$0.03
Change-$0.00 (-0.00%)
Volume$58.9K
Capitalization45.13M
CLGN vs NEVPF Comparison Chart in %
Loading...
CLGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CLGN vs. NEVPF commentary
Sep 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLGN is a StrongBuy and NEVPF is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 28, 2025
Stock price -- (CLGN: $3.14 vs. NEVPF: $0.03)
Brand notoriety: CLGN and NEVPF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLGN: 133% vs. NEVPF: 100%
Market capitalization -- CLGN: $39.93M vs. NEVPF: $45.13M
CLGN [@Biotechnology] is valued at $39.93M. NEVPF’s [@Biotechnology] market capitalization is $45.13M. The market cap for tickers in the [@Biotechnology] industry ranges from $98.9B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLGN’s FA Score shows that 1 FA rating(s) are green whileNEVPF’s FA Score has 0 green FA rating(s).

  • CLGN’s FA Score: 1 green, 4 red.
  • NEVPF’s FA Score: 0 green, 5 red.
According to our system of comparison, CLGN is a better buy in the long-term than NEVPF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLGN’s TA Score shows that 5 TA indicator(s) are bullish.

  • CLGN’s TA Score: 5 bullish, 4 bearish.

Price Growth

CLGN (@Biotechnology) experienced а +24.85% price change this week, while NEVPF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.00%. For the same industry, the average monthly price growth was +9.18%, and the average quarterly price growth was +54.60%.

Reported Earning Dates

CLGN is expected to report earnings on Nov 26, 2025.

Industries' Descriptions

@Biotechnology (+4.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NEVPF($45.1M) has a higher market cap than CLGN($39.9M). CLGN YTD gains are higher at: -12.778 vs. NEVPF (-22.222). CLGN has higher annual earnings (EBITDA): -12.37M vs. NEVPF (-87.99M). NEVPF has more cash in the bank: 32.7M vs. CLGN (11.4M). CLGN has higher revenues than NEVPF: CLGN (2.4M) vs NEVPF (0).
CLGNNEVPFCLGN / NEVPF
Capitalization39.9M45.1M88%
EBITDA-12.37M-87.99M14%
Gain YTD-12.778-22.22257%
P/E RatioN/AN/A-
Revenue2.4M0-
Total Cash11.4M32.7M35%
Total Debt3.03MN/A-
FUNDAMENTALS RATINGS
CLGN vs NEVPF: Fundamental Ratings
CLGN
NEVPF
OUTLOOK RATING
1..100
9150
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
89
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9899
PRICE GROWTH RATING
1..100
3941
P/E GROWTH RATING
1..100
1100
SEASONALITY SCORE
1..100
855

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NEVPF's Valuation (89) in the null industry is in the same range as CLGN (94) in the Biotechnology industry. This means that NEVPF’s stock grew similarly to CLGN’s over the last 12 months.

NEVPF's Profit vs Risk Rating (100) in the null industry is in the same range as CLGN (100) in the Biotechnology industry. This means that NEVPF’s stock grew similarly to CLGN’s over the last 12 months.

CLGN's SMR Rating (98) in the Biotechnology industry is in the same range as NEVPF (99) in the null industry. This means that CLGN’s stock grew similarly to NEVPF’s over the last 12 months.

CLGN's Price Growth Rating (39) in the Biotechnology industry is in the same range as NEVPF (41) in the null industry. This means that CLGN’s stock grew similarly to NEVPF’s over the last 12 months.

CLGN's P/E Growth Rating (1) in the Biotechnology industry is significantly better than the same rating for NEVPF (100) in the null industry. This means that CLGN’s stock grew significantly faster than NEVPF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CLGNNEVPF
RSI
ODDS (%)
Bearish Trend 3 days ago
80%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
Momentum
ODDS (%)
Bullish Trend 3 days ago
77%
N/A
MACD
ODDS (%)
Bullish Trend 3 days ago
80%
N/A
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
14%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
14%
Advances
ODDS (%)
Bullish Trend 3 days ago
81%
N/A
Declines
ODDS (%)
Bearish Trend 7 days ago
87%
N/A
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
87%
N/A
Aroon
ODDS (%)
Bullish Trend 6 days ago
83%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
CLGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KRP13.870.26
+1.91%
Kimbell Royalty Partners LP
BFAM108.521.24
+1.16%
Bright Horizons Family Solutions
JMSB20.28N/A
N/A
John Marshall Bancorp
UL59.28-0.05
-0.08%
Unilever plc
CCEL4.80-0.05
-1.03%
Cryo-Cell International

CLGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLGN has been loosely correlated with SPRO. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if CLGN jumps, then SPRO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLGN
1D Price
Change %
CLGN100%
+10.95%
SPRO - CLGN
42%
Loosely correlated
-2.58%
CLLS - CLGN
33%
Poorly correlated
+1.20%
ALZN - CLGN
29%
Poorly correlated
+2.12%
NEVPF - CLGN
26%
Poorly correlated
N/A
CVM - CLGN
24%
Poorly correlated
+5.17%
More

NEVPF and

Correlation & Price change

A.I.dvisor indicates that over the last year, NEVPF has been loosely correlated with CELC. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if NEVPF jumps, then CELC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NEVPF
1D Price
Change %
NEVPF100%
N/A
CELC - NEVPF
61%
Loosely correlated
-2.58%
ADAP - NEVPF
56%
Loosely correlated
+15.75%
VYNE - NEVPF
52%
Loosely correlated
+5.00%
THAR - NEVPF
51%
Loosely correlated
+3.78%
PMN - NEVPF
49%
Loosely correlated
+2.46%
More